Back to Results
First PageMeta Content
Neurotransmitters / Neurotransmitter transporters / Catecholamines / Organofluorides / Selective serotonin reuptake inhibitors / Serotonin–norepinephrine–dopamine reuptake inhibitor / Antidepressant / Monoamine transporter / Serotonin–norepinephrine reuptake inhibitor / Chemistry / Biology / Biochemistry


11 A New Class of Antidepressant Drugs in the Treatment of Psychiatric Disorders: The Triple Reuptake Inhibitors B.P. Guiard
Add to Reading List

Document Date: 2014-05-17 09:51:25

Open Document

File Size: 407,40 KB

Share Result on Facebook

City

Châtenay-Malabry / Paris / /

Company

Lundbeck / Dell / Eli Lilly / A7 / Johnson & Johnson / Wilson / A1 / A2 / Albany Molecular Research Institute Inc / SSb / DOV Pharmaceutical Inc. / Sepracor Inc. / A5 / Lundbeck laboratories / /

Continent

Europe / /

Country

France / /

Event

FDA Phase / /

IndustryTerm

axonal network / neurotransmitter systems / monoaminergic systems / relative equipment / diet-induced negative energy balance / noradrenergic and serotonergic systems / reduced food intake / mental energy / Treatment of Psychiatric Disorders / treatment of obesity / energy / /

MedicalCondition

equilibrium dissociation / physical fatigue / insomnia / bulimia nervosa / dysfunction / zona / hypersomnia / atypical depression / pain / Mental fatigue / Psychiatric Disorders / Fatigue / obesity / Eating disorders / anorexia nervosa / depression / comorbid anxiety disorders / disorders / /

MedicalTreatment

antidepressant therapy / /

Organization

Mayo Foundation / There / /

Product

fluoxetine / reserpine / Monoaminergic / DA / Europe / /

ProvinceOrState

Nebraska / Maryland / /

SocialTag